Clinical Trial Update: Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Plasmid DNA Therapeutic Vaccine(GX-188E) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial to evaluate the safety and efficacy of GX-188E plasmid DNA therapeutic vaccine for cervical intraepithelial neoplasia; current status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Drugs mentioned

• GX-188E (GX-188E DNA vaccine)

Snippet

Sponsor: Genexine, Inc. | Conditions: Cervical Intraepithelial Neoplasia | Phase 2 | Status: UNKNOWN